Journal of Infection

Article	Citations
Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19	768
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study	454
Emergence of a new SARS-CoV-2 variant in the UK	219
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?	186
Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19	181
Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies	168
COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients	158
The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients	140
First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics	135
Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK	120
The duration of infectiousness of individuals infected with SARS-CoV-2	118
SARS-CoV-2 (COVID-19) superspreader events	116
Transmission of monkeypox virus through sexual contact – A novel route of infection	115
Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects	113
Household transmission of COVID-19-a systematic review and meta-analysis	110
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review	109
Post-COVID-19 functional status six-months after hospitalization	100
Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden – a systematic review	99
Excess mortality due to COVID-19 in Germany	96
Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients	94
Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers	93
Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups	91
Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection	89
Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load	86
Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals	84

Antibody titers and protection against a SARS-CoV-2 infection	83
Evidence for lack of transmission by close contact and surface touch in a restaurant outbreak of COVID-19	69
Antibiotic exposure and adverse long-term health outcomes in children: A systematic review and meta-analysis	68
A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection	66
Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study	66
Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration	65
SARS-CoV-2 has displaced other seasonal respiratory viruses: Results from a prospective cohort study	65
SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: Prospective, national observational cohort surveillance, July-December 2020, England	62
Setting the criteria for SARS-CoV-2 reinfection – six possible cases	61
Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study	61
Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers	61
The estimation of diagnostic accuracy of tests for COVID-19: A scoping review	61
Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary	59
Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks	59
Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK	58
COVID-19 associated invasive candidiasis	58
Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals	54
The potential indicators for pulmonary fibrosis in survivors of severe COVID-19	54
Meningococcal disease surveillance in the Asia–Pacific region (2020): The global meningococcal initiative	54
The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19	53
Disease severity during SARS-COV-2 reinfection: a nationwide study	52
Complications and mortality of typhoid fever: A global systematic review and meta-analysis	52
Efficacy and safety of Paxlovid for COVID-19:a meta-analysis	51
Analytical and clinical performance of the panbio COVID-19 antigen-detecting rapid diagnostic test	51
Effect of early application of social distancing interventions on COVID-19 mortality over the first pandemic wave: An analysis of longitudinal data from 37 countries	51
TB-QUICK: CRISPR-Cas12b-assisted rapid and sensitive detection of Mycobacterium tuberculosis	51
The presence of Pneumocystis jirovecii in critically ill patients with COVID-19	50
Discovery of a SARS-CoV-2 variant from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan	50
Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case series	50
Sources and transmission routes of campylobacteriosis: A combined analysis of genome and exposure data	50
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England	49
Risk communication on behavioral responses during COVID-19 among general population in China: A rapid national study	49
Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021	48
Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening	48
Anxiety, depression and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: A multicenter study	48
Artificial intelligence, machine learning and deep learning: Potential resources for the infection clinician	48
Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis	47
Changes in paediatric respiratory infections at a UK teaching hospital 2016–2021; impact of the SARS-CoV-2 pandemic	46
Incidence and disease burden of herpes zoster in the population aged ≥50 years in China: Data from an integrated health care network	46
Emergence of co-infection of COVID-19 and dengue: A serious public health threat	45
Risk factors for Coronavirus disease-associated mucormycosis	45
Panbio™ rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care	44
First case of monkeypox virus, SARS-CoV-2 and HIV co-infection	44
Serum Ferritin is an independent risk factor for Acute Respiratory Distress Syndrome in COVID-19	44
Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review	44
Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: A preliminary report.	44
Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers	43
In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy	43
Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison	42
Decrease in norovirus infections in Germany following COVID-19 containment measures	42

Public health effects of travel-related policies on the COVID-19 pandemic: A mixed-methods systematic review	42
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.	42
Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months	41
Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India	41
Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department	40
Magnetic resonance imaging of COVID-19 anosmic patients reveals abnormalities of the olfactory bulb: Preliminary prospective study	40
IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression	40
Healthcare-associated COVID-19 in England: A national data linkage study	39
Monkeypox infection among men who have sex with men: PCR testing on seminal fluids	39
COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy	39
Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination	39
Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19	38
Transmission of SARS-CoV-2 in the household setting: A prospective cohort study in children and adults in England	38
Incidence of non-typhoidal Salmonella invasive disease: A systematic review and meta-analysis	38
Global magnitude of encephalitis burden and its evolving pattern over the past 30 years	38
Predicting the diagnosis of HIV and sexually transmitted infections among men who have sex with men using machine learning approaches	38
Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals	38
Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection	37
Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of COVID-19	37
Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection	37
Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: A prospective surveillance study	37
Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with COVID-19	37
Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study	37
Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery	37
Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end?	36
Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico	35
Ocular involvement in monkeypox: Description of an unusual presentation during the current outbreak	34
COVID-19 is more severe in patients with hypertension; ACEI/ARB treatment does not influence clinical severity and outcome	34
Transmission of SARS-CoV-2 by children and young people in households and schools: A meta-analysis of population-based and contact-tracing studies	34
Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: A retrospective cohort study	34
Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjects	34
Evidence of SARS-CoV-2 re-infection with a different genotype	34
Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: A large multicentre case–control and cohort study	33
Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance	33
Prior presumed coronavirus infection reduces COVID-19 risk: A cohort study	33
Mobile health technology combats COVID-19 in China	33
Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?	32
Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: A systematic review	32
First two cases of Monkeypox virus infection in travellers returned from UAE to India, July 2022	32
Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: A systematic review and meta-analysis	32
Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2	32
Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19	32
Post-sequelae one year after hospital discharge among older COVID-19 patients: A multi-center prospective cohort study	32
Epidemiology and clinical outcomes of severe Plasmodium vivax malaria in India	32
Immunocompromised children and young people are at no increased risk of severe COVID-19	31
Disparities in the excess risk of mortality in the first wave of COVID-19: Cross sectional study of the English sentinel network	31
A child with acute respiratory distress syndrome caused by avian influenza H3N8 virus	31
Infection rates of 70% of the population observed within 3 weeks after release of COVID-19 restrictions in Macao, China	31
Mucormycosis—A serious threat in the COVID-19 pandemic?	31
Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation	31
Fecal Microbiota Transplantation for multidrug-resistant organism: Efficacy and Response prediction	30
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study	30
Prevalence of cervicovaginal human papillomavirus infection and genotypes in the pre-vaccine era in China: A nationwide population-based study	30
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers	30
SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on	30
Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers	29
Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak	29
Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in France	29
European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study	29
Fighting Omicron epidemic in China: Real-world big data from Fangcang shelter hospital during the outbreak in Shanghai 2022	29
Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay	29
Methods to evaluate serogroup B meningococcal vaccines: From predictions to real-world evidence	29
Lower household transmission rates of SARS-CoV-2 from children compared to adults	29
Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review	29
Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination	29
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study	28
Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis	28
Targeting F13 from monkeypox virus and variola virus by tecovirimat: Molecular simulation analysis	27
Redefining Staphylococcus aureus bacteremia: A structured approach guiding diagnostic and therapeutic management	27
SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study	27
Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies	27
Developing new therapeutic approaches for treating infections caused by multi-drug resistant Acinetobacter baumannii	27
High rate of reinfection with the SARS-CoV-2 Omicron variant	27
Point-of-care evaluation of a rapid antigen test (CLINITESTⓇ Rapid COVID-19 Antigen Test) for diagnosis of SARS-CoV-2 infection in symptomatic and asymptomatic individuals	27
High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection	27
Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection	27
Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant	27
Home-based SARS-CoV-2 lateral flow antigen testing in hospital workers	26
Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England	26
Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitu	26

Distinguishing septic shock from non-septic shock in postsurgical patients using gene expression	26
Antiviral effect of azvudine and nirmatrelvir-ritonavir among hospitalized patients with COVID-19	26
COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity	26
Rapid multiplex PCR for respiratory viruses reduces time to result and improves clinical care: Results of a systematic review and meta-analysis	25
Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas	25
Targeted next generation sequencing is comparable with metagenomic next generation sequencing in adults with pneumonia for pathogenic microorganism detection	25
Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees	25
Changes in Streptococcus pneumoniae infection in children before and after the COVID-19 pandemic in Zhengzhou, China	25
Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study	25
Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: A comparison of patients with and without SARS-CoV-2 infection	25
Antibody titers and breakthrough infections with Omicron SARS-CoV-2	25
Impact of the timeliness of antibiotic therapy on the outcome of patients with sepsis and septic shock	25
Distinguishing bacterial versus non-bacterial causes of febrile illness – A systematic review of host biomarkers	25
Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant	25
Epidemiology of complex bone and joint infections in France using a national registry: The CRIOAc network	24
Re-emergence of Severe Acute Diarrhea Syndrome Coronavirus (SADS-CoV) in Guangxi, China, 2021	24
Analysis of online search trends suggests that SARS-CoV-2 Omicron (B.1.1.529) variant causes different symptoms	24
How China responds to Omicron	24
Decline in pneumococcal disease incidence in the time of COVID-19 in Singapore	24
The incubation period of the SARS-CoV-2 B1.1.7 variant is shorter than that of other strains	24
Medical features of COVID-19 and influenza infection: A comparative study in Paris, France	24
Neutrophil-to-lymphocyte ratio on admission is an independent risk factor for the severity and mortality in patients with coronavirus disease 2019	24
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features	24
Improved sensitivity using a dual target, E and RdRp assay for the diagnosis of SARS-CoV-2 infection: Experience at a large NHS Foundation Trust in the UK	24
Safety and efficacy of the COVID-19 vaccine in children and/or adolescents:A meta-analysis	23
Serum cholinesterase associated with COVID-19 pneumonia severity and mortality	23
Molecular surveillance of HIV-1 newly diagnosed infections in Shenzhen, China from 2011 to 2018	23
Utility of plasma cell-free DNA next-generation sequencing for diagnosis of infectious diseases in patients with hematological disorders	23
Use of lateral flow devices allows rapid triage of patients with SARS-CoV-2 on admission to hospital	23
Rapid COVID-19 rebound in a severe COVID-19 patient during 20-day course of Paxlovid	23
First, second and third wave of COVID-19. What have we changed in the ICU management of these patients?	23
Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study	23
Characteristics and risk factors of prolonged viable virus shedding in immunocompromised patients with COVID-19: a prospective cohort study	22
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected	22
Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients	22
Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScopeⓇ—Global Registry for Emerging Fungal Infections	22
Extrahepatic manifestations related to hepatitis E virus infection and their triggering mechanisms	22
Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment	22
Comparing the 4C mortality score for COVID-19 to established scores (CURB65, CRB65, qSOFA, NEWS) for respiratory infection patients	22
Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination	22
Long-term impact of COVID-19 associated acute respiratory distress syndrome	22
Cytomegalovirus infection in critically ill patients with COVID-19	22
Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and -B bronchiolitis before and after pandemic restrictions in Rome	22
Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study	21
The dilemma of COVID-19 recurrence after clinical recovery	21
Fecal microbiota transplantation for Carbapenem-Resistant Enterobacteriaceae: A systematic review	21
4CMenB sustained vaccine effectiveness against invasive meningococcal B disease and gonorrhoea at three years post programme implementation	21
Ct value is not enough to discriminate patients harbouring infective virus	21
Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ	21
Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy.	21
Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: A subsequent study of a national survey	20
The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population	20
A distinct phylogenetic cluster of Monkeypox genomes suggests an early and cryptic spread of the virus	20
Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort	20
Monkeypox: A new threat at our doorstep!	20
Will achieving herd immunity be a road to success to end the COVID-19 pandemic?	20
The potential impact of vulnerability and coping capacity on the pandemic control of COVID-19	20
Interleukin-6 and Mycobacterium tuberculosis dormancy antigens improve diagnosis of tuberculosis	20
WITHDRAWN: The whole genome analysis for the first human infection with H10N3 influenza virus in China	20
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients	20
Clinical and virological characteristics of SARS-CoV-2 Omicron BA.2.2 variant outbreaks during April to May, 2022, Shanghai, China	20
The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients	20
Monkeypox and pan-resistant Campylobacter spp infection in Entamoeba histolytica and Chlamydia trachomatis re-infection in a man who have sex with men	20
Etiology and prevalence of ESBLs in adult community-onset urinary tract infections in East China: A prospective multicenter study	19
Identification of a novel HIV-1 second-generation Circulating Recombinant Form CRF109_0107 in China	19
Differences between the waves in Northern Italy: How the characteristics and the outcome of COVID-19 infected patients admitted to the emergency room have changed	19
Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study	19
Identification of a new HIV-1 intersubtype circulating recombinant form (CRF123_0107) in Hebei province, China	19
British Infection Association guidelines for the diagnosis and management of enteric fever in England	19
Adjusted control rate closely associated with the epidemiologic evolution of the recent COVID-19 wave in Shanghai, with 94.3% of all new cases being asymptomatic on first diagnosis	19
Comparison of saliva and nasopharyngeal swab SARS-CoV-2 RT-qPCR testing in a community setting	19
The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients	19
Impact of COVID-19 preventive measures on other infectious and non-infectious respiratory diseases in Pakistan	19
Sex differences in sepsis hospitalisations and outcomes in older women and men: A prospective cohort study	19
N-acetylcysteine for the treatment of COVID-19 among hospitalized patients	18
Quality of life after COVID-19 without hospitalisation: Good overall, but reduced in some dimensions	18
Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the delta wave and vaccination	18
Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination	18
Wild bird-origin H3N8 avian influenza virus exhibit well adaptation in mammalian host	18
Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: Results of a randomised controlled trial	18
A single dose of doxycycline after an ixodes ricinus tick bite to prevent Lyme borreliosis: An open-label randomized controlled trial	18
Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection	17
Clinical features and outcomes of hospitalized patients with COVID-19 during the Omicron wave in Shanghai, China	17
Interferon-induced transmembrane protein 3 gene polymorphisms are associated with COVID-19 susceptibility and severity: A meta-analysis	17
Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan	17
Comprehensive identification of immuno-related transcriptional signature for active pulmonary tuberculosis by integrated analysis of array and single cell RNA-seq	17
Machine learning based on routine laboratory indicators promoting the discrimination between active tuberculosis and latent tuberculosis infection	17
Development and evaluation of a nanopore 16S rRNA gene sequencing service for same day targeted treatment of bacterial respiratory infection in the intensive care unit	17
Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital	17
Stool-based Xpert MTB/RIF Ultra assay as a tool for detecting pulmonary tuberculosis in children with abnormal chest imaging: A prospective cohort study	17
SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022	17
The value of electrostatic potentials of the spike receptor binding and N-terminal domains in addressing transmissibility and infectivity of SARS-CoV-2 variants of concern	17
Successful case of adjunctive intravenous bacteriophage therapy to treat left ventricular assist device infection	17
Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection	17
Identification of recently identified tick-borne viruses (Dabieshan tick virus and SFTSV) by metagenomic analysis in ticks from Shandong Province, China	17